S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?

Nutex Health (NUTX) Stock Price, News & Analysis

$0.10
0.00 (0.00%)
(As of 03/27/2024 ET)
Today's Range
$0.10
$0.10
50-Day Range
$0.10
$0.19
52-Week Range
$0.09
$1.10
Volume
646,796 shs
Average Volume
1.80 million shs
Market Capitalization
$68.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.00

Nutex Health MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
880.4% Upside
$1.00 Price Target
Short Interest
Healthy
0.34% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.30 out of 5 stars

Medical Sector

469th out of 939 stocks

Business Services, Not Elsewhere Classified Industry

57th out of 91 stocks

NUTX stock logo

About Nutex Health Stock (NASDAQ:NUTX)

Nutex Health Inc. operates as a network of micro-hospitals. It operates through three segments: Hospital, Population Health Management, and Real Estate. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. The Population Health Management segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment leases land and hospital building. It also provides healthcare and facility management services; and healthcare billing, coding, and collection services. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

NUTX Stock Price History

NUTX Stock News Headlines

[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
Nutex Prices Direct Offering, Stock Plummets In Pre-market
Nutex Health Inc NUTX
Thomas Vo Spends US$114k On Nutex Health Stock
NUTEX HEALTH REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS
Nutex Health Inc.
See More Headlines
Receive NUTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Next Earnings (Estimated)
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:NUTX
Employees
1,150
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.00
High Stock Price Target
$1.00
Low Stock Price Target
$1.00
Potential Upside/Downside
+880.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-424,780,000.00
Pretax Margin
-11.49%

Debt

Sales & Book Value

Annual Sales
$219.29 million
Book Value
$0.19 per share

Miscellaneous

Free Float
345,587,000
Market Cap
$68.42 million
Optionable
Not Optionable
Beta
0.46
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Thomas T. Vo M.B.A. (Age 51)
    M.D., Chairman of the Board & CEO
    Comp: $938.23k
  • Dr. Warren Hosseinion M.D. (Age 52)
    President & Director
    Comp: $937.66k
  • Mr. Jon C. Bates CPA (Age 53)
    M.B.A., Chief Financial Officer
    Comp: $299.46k
  • Ms. Pamela W. Montgomery B.S.N. (Age 58)
    J.D., L.L.M., M.S.N., R.N., Chief Legal Officer of Healthcare & Board Secretary
    Comp: $275.36k
  • Ms. Elisa Michael Luqman Esq. (Age 60)
    J.D., M.B.A., Chief Legal Officer (SEC) & Board Secretary
    Comp: $251.33k
  • Mr. Joshua DeTillio FACHE
    M.B.A., Chief Operating Officer
  • Ms. LaChoenda Rosales
    Director of Accounting
  • LaTanya Brackens
    Director of Compliance
  • Ms. Vivian Sanders M.B.A.
    Director of Marketing
  • Sarah Wallace
    Director of Human Resources

NUTX Stock Analysis - Frequently Asked Questions

Should I buy or sell Nutex Health stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutex Health in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NUTX shares.
View NUTX analyst ratings
or view top-rated stocks.

What is Nutex Health's stock price target for 2024?

1 equities research analysts have issued 1-year price objectives for Nutex Health's stock. Their NUTX share price targets range from $1.00 to $1.00. On average, they anticipate the company's share price to reach $1.00 in the next twelve months. This suggests a possible upside of 880.4% from the stock's current price.
View analysts price targets for NUTX
or view top-rated stocks among Wall Street analysts.

How have NUTX shares performed in 2024?

Nutex Health's stock was trading at $0.18 on January 1st, 2024. Since then, NUTX shares have decreased by 43.3% and is now trading at $0.1020.
View the best growth stocks for 2024 here
.

When is Nutex Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 28th 2024.
View our NUTX earnings forecast
.

Who are Nutex Health's major shareholders?

Nutex Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (1.89%), Vanguard Group Inc. (1.89%), Truist Financial Corp (0.65%), GDS Wealth Management (0.17%), Beaird Harris Wealth Management LLC (0.14%) and Northern Trust Corp (0.10%). Insiders that own company stock include John J Waters, Joshua Detillio, Michael Lee Reed, Pamela W Montgomery and Thomas T Vo.
View institutional ownership trends
.

How do I buy shares of Nutex Health?

Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NUTX) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners